Litoxetine

N/A

Report date: 2024/05/30 20:00:07
NME

Base Information

Drug NameLitoxetine
Drug Alias NameIXA-001SL-810385
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin (5-HT) receptor antagonistsSerotonin reuptake inhibitors
TargetsSerotonin (5-HT) receptorSerotonin transporter
Therapy Area/IndicationsUrinary Incontinence
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIxaltis Sa
Active IndicationsN/A
Inactive IndicationsUrinary Incontinence

Other Information

ATC CodeN/A
Related LinksWikipedia